37111378|t|Oleoylethanolamide Protects against Acute Ischemic Stroke by Promoting PPARalpha-Mediated Microglia/Macrophage M2 Polarization.
37111378|a|Oleoylethanolamide (OEA) has been demonstrated to be a feasible protectant in ischemic stroke. However, the mechanism for OEA-afforded neuroprotection remains elusive. The present study aimed to investigate the neuroprotective effects of OEA on peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated microglia M2 polarization after cerebral ischemia. Transient middle cerebral artery occlusion (tMCAO) was induced for 1 h in wild-type (WT) or PPARalpha-knock-out (KO) mice. Mouse small glioma cells (BV2) microglia and primary microglia cultures were used to evaluate the direct effect of OEA on microglia. A coculture system was used to further elucidate the effect of OEA on microglial polarization and ischemic neurons' fate. OEA promoted the microglia switch from an inflammatory M1 phenotype to the protective M2 phenotype and enhanced the binding of PPARalpha with the arginase1 (Arg1) and Ym1 promoter in WT mice but not in KO mice after MCAO. Notably, the increased M2 microglia caused by OEA treatment were strongly linked to neuron survival after ischemic stroke. In vitro studies confirmed that OEA shifted BV2 microglia from (lipopolysaccharide) LPS-induced M1-like to M2-like phenotype through PPARalpha. Additionally, the activation of PPARalpha in primary microglia by OEA led to an M2 protective phenotype that enhanced neuronal survival against oxygen-glucose deprivation (OGD) in the coculture systems. Our findings demonstrate the novel effects of OEA in enhancing microglia M2 polarization to protect neighboring neurons by activating the PPARalpha signal, which is a new mechanism of OEA against cerebral ischemic injury. Therefore, OEA might be a promising therapeutic drug for stroke and targeting PPARalpha-mediated M2 microglia may represent a new strategy to treat ischemic stroke.
37111378	0	18	Oleoylethanolamide	Chemical	MESH:C488250
37111378	36	57	Acute Ischemic Stroke	Disease	MESH:D000083242
37111378	71	80	PPARalpha	Gene	19013
37111378	128	146	Oleoylethanolamide	Chemical	MESH:C488250
37111378	148	151	OEA	Chemical	MESH:C488250
37111378	206	221	ischemic stroke	Disease	MESH:D002544
37111378	250	253	OEA	Chemical	MESH:C488250
37111378	366	369	OEA	Chemical	MESH:C488250
37111378	373	421	peroxisome proliferator-activated receptor alpha	Gene	19013
37111378	423	432	PPARalpha	Gene	19013
37111378	475	492	cerebral ischemia	Disease	MESH:D002545
37111378	504	536	middle cerebral artery occlusion	Disease	MESH:D020244
37111378	538	543	tMCAO	Disease	MESH:D020244
37111378	586	595	PPARalpha	Gene	19013
37111378	611	615	mice	Species	10090
37111378	617	622	Mouse	Species	10090
37111378	629	635	glioma	Disease	MESH:D005910
37111378	643	646	BV2	CellLine	CVCL:0182
37111378	732	735	OEA	Chemical	MESH:C488250
37111378	813	816	OEA	Chemical	MESH:C488250
37111378	848	864	ischemic neurons	Disease	MESH:D002545
37111378	872	875	OEA	Chemical	MESH:C488250
37111378	914	926	inflammatory	Disease	MESH:D007249
37111378	999	1008	PPARalpha	Gene	19013
37111378	1018	1027	arginase1	Gene	11846
37111378	1029	1033	Arg1	Gene	11846
37111378	1039	1042	Ym1	Gene	12655
37111378	1058	1062	mice	Species	10090
37111378	1077	1081	mice	Species	10090
37111378	1088	1092	MCAO	Disease	
37111378	1140	1143	OEA	Chemical	MESH:C488250
37111378	1200	1215	ischemic stroke	Disease	MESH:D002544
37111378	1249	1252	OEA	Chemical	MESH:C488250
37111378	1261	1264	BV2	CellLine	CVCL:0182
37111378	1281	1299	lipopolysaccharide	Chemical	MESH:D008070
37111378	1301	1304	LPS	Chemical	MESH:D008070
37111378	1350	1359	PPARalpha	Gene	19013
37111378	1393	1402	PPARalpha	Gene	19013
37111378	1427	1430	OEA	Chemical	MESH:C488250
37111378	1505	1511	oxygen	Chemical	MESH:D010100
37111378	1512	1519	glucose	Chemical	MESH:D005947
37111378	1610	1613	OEA	Chemical	MESH:C488250
37111378	1702	1711	PPARalpha	Gene	19013
37111378	1748	1751	OEA	Chemical	MESH:C488250
37111378	1760	1784	cerebral ischemic injury	Disease	MESH:D017202
37111378	1797	1800	OEA	Chemical	MESH:C488250
37111378	1843	1849	stroke	Disease	MESH:D020521
37111378	1864	1873	PPARalpha	Gene	19013
37111378	1934	1949	ischemic stroke	Disease	MESH:D002544
37111378	Association	12655	19013
37111378	Negative_Correlation	MESH:C488250	MESH:D002544
37111378	Positive_Correlation	MESH:C488250	19013
37111378	Positive_Correlation	MESH:C488250	11846
37111378	Association	MESH:D008070	19013
37111378	Association	MESH:D017202	19013
37111378	Association	MESH:C488250	12655
37111378	Association	MESH:C488250	MESH:D008070
37111378	Negative_Correlation	MESH:C488250	MESH:D017202
37111378	Association	MESH:D002544	19013
37111378	Negative_Correlation	MESH:C488250	MESH:D000083242
37111378	Negative_Correlation	MESH:C488250	MESH:D020521
37111378	Association	11846	19013
37111378	Association	MESH:C488250	MESH:D010100

